Rhumbline Advisers grew its holdings in shares of Alteryx Inc (NYSE:AYX) by 49.9% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 38,795 shares of the company’s stock after purchasing an additional 12,923 shares during the quarter. Rhumbline Advisers owned approximately 0.06% of Alteryx worth $2,307,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other institutional investors have also recently added to or reduced their stakes in the stock. Capital World Investors raised its holdings in Alteryx by 87.8% during the 3rd quarter. Capital World Investors now owns 3,230,433 shares of the company’s stock valued at $184,813,000 after buying an additional 1,510,000 shares during the period. Renaissance Technologies LLC increased its stake in Alteryx by 444.3% in the third quarter. Renaissance Technologies LLC now owns 894,298 shares of the company’s stock worth $51,163,000 after purchasing an additional 730,000 shares during the period. Franklin Resources Inc. increased its stake in Alteryx by 644.7% in the third quarter. Franklin Resources Inc. now owns 773,719 shares of the company’s stock worth $44,264,000 after purchasing an additional 669,819 shares during the period. Capital International Investors purchased a new stake in Alteryx in the third quarter worth $32,953,000. Finally, Deutsche Bank AG increased its stake in Alteryx by 304.2% in the third quarter. Deutsche Bank AG now owns 642,860 shares of the company’s stock worth $36,776,000 after purchasing an additional 483,810 shares during the period. 54.96% of the stock is owned by institutional investors.
A number of analysts have weighed in on the company. Wedbush increased their target price on Alteryx from $72.00 to $76.00 and gave the stock a “neutral” rating in a research note on Thursday, February 28th. Citigroup raised their price target on Alteryx from $85.00 to $93.00 and gave the company a “buy” rating in a research note on Friday, March 1st. JPMorgan Chase & Co. raised their price objective on Alteryx to $70.00 and gave the company a “neutral” rating in a research report on Thursday, February 28th. DA Davidson raised their price objective on Alteryx to $74.00 and gave the company a “neutral” rating in a research report on Thursday, February 28th. They noted that the move was a valuation call. Finally, TheStreet downgraded Alteryx from a “c” rating to a “d+” rating in a research report on Thursday, February 28th. Five investment analysts have rated the stock with a hold rating and nine have given a buy rating to the company’s stock. The company has a consensus rating of “Buy” and a consensus price target of $78.17.Shares of Alteryx stock traded up $0.19 on Wednesday, reaching $76.25. 19,742 shares of the stock were exchanged, compared to its average volume of 1,094,633. The company has a quick ratio of 2.64, a current ratio of 2.64 and a debt-to-equity ratio of 0.88. Alteryx Inc has a twelve month low of $30.45 and a twelve month high of $79.97. The company has a market capitalization of $4.72 billion, a price-to-earnings ratio of -382.30 and a beta of 1.10.
Alteryx (NYSE:AYX) last released its earnings results on Wednesday, February 27th. The company reported ($0.01) EPS for the quarter, topping the Zacks’ consensus estimate of ($0.02) by $0.01. Alteryx had a negative return on equity of 7.06% and a negative net margin of 6.72%. The firm had revenue of $60.50 million during the quarter, compared to the consensus estimate of $57.59 million. During the same quarter in the previous year, the company posted $0.02 earnings per share. The company’s revenue was up 56.7% compared to the same quarter last year. Research analysts anticipate that Alteryx Inc will post 0.06 EPS for the current fiscal year.
In other news, SVP Christopher M. Lal sold 795 shares of the business’s stock in a transaction that occurred on Friday, December 14th. The stock was sold at an average price of $61.48, for a total value of $48,876.60. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO Kevin Rubin sold 8,500 shares of the business’s stock in a transaction that occurred on Monday, January 14th. The shares were sold at an average price of $67.46, for a total value of $573,410.00. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 1,405,370 shares of company stock valued at $95,120,596. 39.01% of the stock is owned by company insiders.
TRADEMARK VIOLATION WARNING: This piece was published by Baseball Daily News and is the sole property of of Baseball Daily News. If you are accessing this piece on another publication, it was illegally stolen and reposted in violation of US & international copyright and trademark legislation. The correct version of this piece can be read at https://www.baseballdailydigest.com/news/2019/03/13/rhumbline-advisers-boosts-stake-in-alteryx-inc-ayx.html.
Alteryx Company Profile
Alteryx, Inc operates a self-service data analytics software platform that enables organizations to enhance business outcomes and the productivity of their business analysts. Its software platform includes Alteryx Designer for data preparation, blending, and analytics that could be deployable in the cloud and on premise; Alteryx Server, a secure and scalable server-based product for scheduling, sharing, and running analytic processes and applications in a Web-based environment; Alteryx Connect, a collaborative data exploration platform for discovering information assets and sharing recommendations across the enterprise; Alteryx Promote, an analytics model management product for data scientists and analytics teams to build, manage, monitor, and deploy predictive models to production; and Alteryx Analytics Gallery, a cloud-based collaboration offering that allows users to share workflows in a centralized repository.
Recommended Story: What are the risks of holding treasury bonds?
Receive News & Ratings for Alteryx Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Alteryx and related companies with MarketBeat.com’s FREE daily email newsletter.